Skip to main content

Eczema Endorsed Content

There is growing evidence to support a hypothesis for the role pain may play in the disease process of atopic dermatitis. Test your knowledge of eczema-related pain with this short quiz!
Lauren Mateja, Managing Editor
Atopic dermatitis is a chronic disease requiring long-term monitoring of symptoms and triggers. Patients can proactively monitor their eczema with a new, easy-to-use mobile app.
Lauren Mateja, Managing Editor
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
Lauren Mateja, Managing Editor
The Centers for Disease Control and Prevention and World Health Organization advise that hand washing is critical to slowing the spread of infection, but patients with dermatitis may need further guidance from their dermatologists.
Lauren Mateja, Managing Editor
A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.
Esther A. Balogh, MD, Elnara Muradova, MS, Lindsay C. Strowd, MD, FAAD
Genetic polymorphisms and defects are commonly found in patients with atopic dermatitis. A more personalized therapy that considers individual genetics and pathogenesis may provide a more effective treatment approach.
Rachel Shireen Golpanian, BA, Kayla Fourzali, MS, Hong Liang Tey, MD, Gil Yosipovitch, MD
Diagnosis of atopic dermatitis in skin of color and in various age groups can be challenging. Understanding the differences in presentation can help with implementing appropriate treatment sooner.
Jill Waldbieser, Managing Editor
Certain atopic dermatitis comorbidities can be treated—but first, dermatologists have to be vigilant about identifying them.
Melissa Weiss, Associate Editor
A review of news, research, and trends related to eczema.
Carlos G. Wambier, MD, PhD, and Brett A. King, MD, PhD
JAK inhibitors appear to be effective for the treatment of AD, and this class of medications will influence the current paradigm of AD management.
Back to Top